Assessment of HPV Vaccine Knowledge Levels Among Medical Faculty Students: A Comprehensive Examination in the Turkish Context HPV Vaccine Knowledge among Turkish Medical Students

Main Article Content

Derya Korkmaz
Hatice Nur Turunç
Yıldırım Alpay Özarslan
Ümmühan İrem Yıldırım
Yusuf Büyükarmutçu
Serkan Dağlı
Barış Manavlı

Abstract

Objective: The primary objective of this study was to measure medical students' knowledge, attitudes, and future professional intentions regarding HPV and its vaccines. This study aims to identify the factors that impact these variables within Turkey's distinctive sociocultural and healthcare landscapes. The insights derived from data analysis can be employed to guide focused educational interventions, aiming to enhance HPV vaccination rates and mitigate HPV-related health outcomes in Turkey.


Material and Methods: Carried out between November and December 2022, this study employed a descriptive and comparative research design to evaluate HPV-related knowledge, attitudes, and intentions among 687 medical students enrolled in the Medical Faculty of Afyonkarahisar Health Sciences University. A comprehensive 20-question survey was administered, covering demographic details, HPV awareness, and attitudes towards vaccination, followed by statistical analysis.


Results: The study population exhibited a mean age of 20.6 years and was predominantly female (60.1%). Overall, 91.6% of the participants were aware of HPV, primarily through their medical education (52.1%) and social media (42.3%). However, only 3.5% of the patients were vaccinated against HPV. Factors influencing vaccine uptake included having close contacts diagnosed with HPV or cervical cancer (p=0.001), gender (p=0.01 for females, p=0.02 for males), and prior HPV awareness (p=0.03). Significant misconceptions existed, notably regarding HPV's association with specific cancers and the vaccine's inclusion in the regular schedule.


Conclusions: According to our study, medical students' attitudes and knowledge about HPV and HPV vaccination are critically important for future healthcare providers and policymakers. HPV-related cancers beyond cervical cancer are poorly understood, and vaccine counselling training is inadequate. Students who had been in close contact with HPV or cervical cancer exhibited a significantly higher likelihood of receiving the vaccine. It is crucial to formulate focused educational strategies that enhance HPV vaccine adherence and provide future medical professionals with the skills to educate patients effectively.

Downloads

Download data is not yet available.

Article Details

How to Cite
Korkmaz, D., Turunç, H. N., Özarslan, Y. A., Yıldırım, Ümmühan İrem, Büyükarmutçu, Y., Dağlı, S., & Manavlı, B. (2023). Assessment of HPV Vaccine Knowledge Levels Among Medical Faculty Students: A Comprehensive Examination in the Turkish Context: HPV Vaccine Knowledge among Turkish Medical Students. Medical Science and Discovery, 10(9), 655–661. https://doi.org/10.36472/msd.v10i9.1033
Section
Research Article
Received 2023-08-28
Accepted 2023-08-30
Published 2023-09-01

References

Zhao F-H, Tiggelaar SM, Hu S-Y, Zhao N, Hong Y, Niyazi M, et al. A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China. Asian Pacific journal of cancer prevention: APJCP. 2012;13(5):2369.

Vickers M, Green CL, Lee HY, Pierce JY, Daniel CL. Factors associated with HPV vaccination uptake and HPV-associated cancers: a county-level analysis in the state of Alabama. Journal of community health. 2019;44:1214-23.

Meites E, Kempe A, Markowitz L. Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the advisory committee on immunization practices. Elsevier; 2017. p. 834-7.

Van Damme P, Meijer CJ, Kieninger D, Schuyleman A, Thomas S, Luxembourg A, et al. A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men. Vaccine. 2016;34(35):4205-12.

Swiecki‐Sikora AL, Henry KA, Kepka D. HPV vaccination coverage among US teens across the rural‐urban continuum. The Journal of Rural Health. 2019;35(4):506-17.

Warner EL, Ding Q, Pappas LM, Henry K, Kepka D. White, affluent, educated parents are least likely to choose HPV vaccination for their children: a cross-sectional study of the National Immunization Study–teen. BMC pediatrics. 2017;17(1):1-13.

Seven M, Güvenç G, Şahin E, Akyüz A. Attitudes to HPV vaccination among parents of children aged 10 to 13 years. Journal of pediatric and adolescent gynecology. 2015;28(5):382-6.

Cartmell KB, Young-Pierce J, McGue S, Alberg AJ, Luque JS, Zubizarreta M, et al. Barriers, facilitators, and potential strategies for increasing HPV vaccination: a statewide assessment to inform action. Papillomavirus Research. 2018;5:21-31.

Yu C, Chen L, Ruan G, An J, Sun P. Evaluation of knowledge and attitude toward hpv and vaccination among medical staff, medical students, and community members in Fujian province. Risk Management and Healthcare Policy. 2020:989-97.

McCusker SM, Macqueen I, Lough G, MacDonald AI, Campbell C, Graham SV. Gaps in detailed knowledge of human papillomavirus (HPV) and the HPV vaccine among medical students in Scotland. BMC public health. 2013;13(1):1-7.

Pandey D, Vanya V, Bhagat S, Vs B, Shetty J. Awareness and attitude towards human papillomavirus (HPV) vaccine among medical students in a premier medical school in India. 2012.

Yeğenler F, Karaman ST, Yeğenler B, Basat O. Evaluatıon of attıtudes and behavıors towards cancer screenıng ın people 30-70 years old.

Berenson AB, Hirth JM, Fuchs EL. US medical students’ willingness to offer the HPV vaccine by vaccination status. Vaccine. 2017;35(9):1212-5.

Afonso NM, Kavanagh MJ, Swanberg SM, Schulte JM, Wunderlich T, Lucia VC. Will they lead by example? Assessment of vaccination rates and attitudes to human papilloma virus in millennial medical students. BMC public health. 2017;17(1):1-8.

Kwan TT, Chan KK, Yip AM, Tam K, Cheung AN, Lee P, et al. Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitative–quantitative study. Sexually transmitted infections. 2008;84(3):227-32.

Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiology Biomarkers & Prevention. 2009;18(2):363-72.

McRee A-L, Reiter PL, Brewer NT. Vaccinating adolescent girls against human papillomavirus—Who decides? Preventive medicine. 2010;50(4):213.

Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics. 2010;126(3):425-33.

Garland SM, Skinner SR, Brotherton JM. Adolescent and young adult HPV vaccination in Australia: achievements and challenges. Preventive medicine. 2011;53:S29-S35.

Ratanasiripong NT. Factors related to human papillomavirus (HPV) vaccination in college men. Public Health Nursing. 2015;32(6):645-53.